4//SEC Filing
Kelderman Kim 4
Accession 0001062993-25-012967
CIK 0000842023other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:04 PM ET
Size
29.4 KB
Accession
0001062993-25-012967
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Kelderman Kim
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-15$44.33/sh+36,132$1,601,732→ 75,136 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-15−36,132→ 48,176 totalExercise: $44.33Exp: 2025-08-08→ Common Stock (36,132 underlying) - Tax Payment
Common Stock
2025-07-15$51.42/sh−32,933$1,693,415→ 42,203 total
Holdings
- 51,261
Performance Restricted Stock Units
→ Common Stock (51,261 underlying) - 115,724
Stock Option (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (115,724 underlying) - 109,536
Stock Option (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (109,536 underlying) - 6,984
Performance Restricted Stock Units
→ Common Stock (6,984 underlying) - 28,940
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (28,940 underlying) - 8,873
Performance Restricted Stock Units
→ Common Stock (8,873 underlying) - 23,881
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (23,881 underlying) - 38,252
Stock Options (Right to Buy)
Exercise: $52.83Exp: 2030-11-01→ Common Stock (38,252 underlying) - 25,944
Stock Option (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (25,944 underlying) - 21,704
Performance Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (21,704 underlying) - 29,391
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (29,391 underlying) - 9,423
Performance Restricted Stock Units
→ Common Stock (9,423 underlying) - 25,945
Performance Stock Options (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (25,945 underlying) - 51,890
Stock Options (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (51,890 underlying) - 25,630
Restricted Stock Units
→ Common Stock (25,630 underlying) - 69,061
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (69,061 underlying)
Footnotes (12)
- [F1]Fully exercisable.
- [F10]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F11]8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
- [F12]Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
- [F2]Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F4]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F5]Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
- [F6]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F7]Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
- [F8]Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
- [F9]Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001739054
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:04 PM ET
- Size
- 29.4 KB